Dr. Jens Eckstein is an accomplished life sciences investor and entrepreneur, currently serving as an Investment Partner at Hevolution. With over two decades of experience in venture capital, company formation, and strategic advisory roles, he focuses on accelerating innovations that enhance human health and longevity.

Before joining Hevolution, Dr. Eckstein held leadership positions at several prominent venture firms, including serving as President of SR One, the corporate venture capital arm of GSK, and as Managing Partner at Apollo Health Ventures. Dr. Eckstein is a Kauffman Fellow, and throughout his career he has guided numerous early-stage biotech and healthcare companies, providing both financial support and strategic counsel. His approach emphasizes strong scientific foundations, transformative technologies, and sustainable business models.

Dr. Eckstein holds a Ph.D. in biological chemistry and has consistently leveraged his scientific training to identify and nurture groundbreaking discoveries. Known for his collaborative leadership style and commitment to rigorous evaluation, he fosters high-impact partnerships that propel the field of healthy ageing forward. Under his guidance, innovative teams have secured significant funding, advanced their pipelines, and forged successful industry alliances.

As an Investment Partner at Hevolution, Dr. Eckstein continues to drive promising ventures toward meaningful progress in prolonging healthspan and improving overall quality of life.”